BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23358260)

  • 1. Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients.
    Tsuji D; Kim YI; Nakamichi H; Daimon T; Suwa K; Iwabe Y; Hayashi H; Inoue K; Yoshida M; Itoh K
    Drug Metab Pharmacokinet; 2013; 28(4):299-304. PubMed ID: 23358260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists.
    Babaoglu MO; Bayar B; Aynacioglu AS; Kerb R; Abali H; Celik I; Bozkurt A
    Clin Pharmacol Ther; 2005 Dec; 78(6):619-26. PubMed ID: 16338277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy.
    Tsuji D; Matsumoto M; Kawasaki Y; Kim YL; Yamamoto K; Nakamichi H; Sahara Y; Makuta R; Yokoi M; Miyagi T; Itoh K
    Cancer Chemother Pharmacol; 2021 Jan; 87(1):73-83. PubMed ID: 33099677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy.
    Ikeda M; Tsuji D; Yamamoto K; Kim YI; Daimon T; Iwabe Y; Hatori M; Makuta R; Hayashi H; Inoue K; Nakamichi H; Shiokawa M; Itoh K
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):149-53. PubMed ID: 25989890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients.
    Lal S; Wong ZW; Sandanaraj E; Xiang X; Ang PC; Lee EJ; Chowbay B
    Cancer Sci; 2008 Apr; 99(4):816-23. PubMed ID: 18377430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients.
    Chang H; Rha SY; Jeung HC; Im CK; Ahn JB; Kwon WS; Yoo NC; Roh JK; Chung HC
    Ann Oncol; 2009 Feb; 20(2):272-7. PubMed ID: 18836089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study.
    Tsuji D; Yokoi M; Suzuki K; Daimon T; Nakao M; Ayuhara H; Kogure Y; Shibata K; Hayashi T; Hirai K; Inoue K; Hama T; Takeda K; Nishio M; Itoh K
    Pharmacogenomics J; 2017 Oct; 17(5):435-440. PubMed ID: 27241063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms.
    Tsai SM; Lin CY; Wu SH; Hou LA; Ma H; Tsai LY; Hou MF
    Clin Chim Acta; 2009 Jun; 404(2):160-5. PubMed ID: 19332043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.
    Panczyk M; Balcerczak E; Piaskowski S; Jamroziak K; Pasz-Walczak G; Mirowski M
    Int J Colorectal Dis; 2009 Aug; 24(8):895-905. PubMed ID: 19415305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
    Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
    Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in CYP1A1 and CYP3A5 Genes Contribute to the Variability in Granisetron Clearance and Exposure in Pregnant Women with Nausea and Vomiting.
    Bustos ML; Zhao Y; Chen H; Caritis SN; Venkataramanan R
    Pharmacotherapy; 2016 Dec; 36(12):1238-1244. PubMed ID: 27809336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ABCB1 (1236C > T, 2677G > T and 3435C > T) polymorphisms on the transport ability of P-gp-mediated sunitinib in Caco-2 cell line.
    Tan DQ
    Xenobiotica; 2020 Mar; 50(3):346-353. PubMed ID: 31023123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1 Polymorphisms and Cold Pressor Pain Responses: Opioid-Dependent Patients on Methadone Maintenance Therapy.
    Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
    Nurs Res; 2017; 66(2):134-144. PubMed ID: 28252574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support.
    Climent MA; Palau J; Ruiz A; Soriano V; Aznar E; Olmos T; Guillem V
    Support Care Cancer; 1998 May; 6(3):287-90. PubMed ID: 9629884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients.
    Turiján-Espinoza E; Ruíz-Rodríguez VM; Uresti-Rivera EE; Martínez-Leija E; Zermeño-Nava JJ; Guel-Pañola A; Romano-Moreno S; Vargas-Morales JM; Portales-Pérez DP
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):843-853. PubMed ID: 33740100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy.
    Knez L; Košnik M; Ovčariček T; Sadikov A; Sodja E; Kern I; Cufer T
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1551-60. PubMed ID: 22543673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.